Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3evb | SAH | Genome polyprotein | 2.1.1.56 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3evb | SAH | Genome polyprotein | 2.1.1.56 | 1.000 | |
| 3eva | SAH | Genome polyprotein | 2.1.1.56 | 0.608 | |
| 5cuq | NSC | Genome polyprotein | / | 0.515 | |
| 5dto | SAH | Genome polyprotein | / | 0.508 | |
| 1l9k | SAH | Genome polyprotein | 2.7.7.48 | 0.507 | |
| 3p97 | SAM | Genome polyprotein | 2.1.1.56 | 0.500 | |
| 5jjr | SAH | Genome polyprotein | / | 0.494 | |
| 2p3q | SAH | Genome polyprotein | / | 0.483 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.483 | |
| 1r6a | SAH | Genome polyprotein | 2.7.7.48 | 0.479 | |
| 2oxt | SAM | Genome polyprotein | / | 0.478 | |
| 3u9e | COA | Lmo1369 protein | / | 0.475 | |
| 1kbj | FMN | Cytochrome b2, mitochondrial | 1.1.2.3 | 0.474 | |
| 4r38 | RBF | Blue-light-activated histidine kinase 2 | 2.7.13.3 | 0.474 | |
| 4ewn | 0VR | Imidazole glycerol phosphate synthase subunit HisF | 4.1.3 | 0.473 | |
| 4ctj | SAM | Genome polyprotein | / | 0.471 | |
| 4wh3 | ATP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.469 | |
| 2p1d | SAH | Genome polyprotein | 2.7.7.48 | 0.464 | |
| 2pd7 | FAD | Vivid PAS protein VVD | / | 0.464 | |
| 3ibq | ATP | Pyridoxal kinase | / | 0.464 | |
| 3mvq | NDP | Glutamate dehydrogenase 1, mitochondrial | 1.4.1.3 | 0.463 | |
| 3a14 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.461 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.458 | |
| 4wh2 | ADP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.458 | |
| 2z6c | FMN | Phototropin-1 | 2.7.11.1 | 0.457 | |
| 4hj4 | FMN | LOV protein | / | 0.456 | |
| 4mok | FAD | Pyranose 2-oxidase | / | 0.455 | |
| 1cjk | FOK | Adenylate cyclase type 2 | / | 0.454 | |
| 1cjk | FOK | Adenylate cyclase type 5 | / | 0.454 | |
| 3vcy | UD1 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | / | 0.454 | |
| 1cul | FOK | Adenylate cyclase type 2 | / | 0.453 | |
| 1cul | FOK | Adenylate cyclase type 5 | / | 0.453 | |
| 2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
| 3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.453 | |
| 3zw9 | NAD | Peroxisomal bifunctional enzyme | 1.1.1.35 | 0.453 | |
| 1u3d | FAD | Cryptochrome-1 | / | 0.451 | |
| 2a1n | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
| 2rkv | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.449 | |
| 4r3a | RBF | Blue-light-activated histidine kinase 2 | 2.7.13.3 | 0.449 | |
| 2j4d | FAD | Cryptochrome DASH, chloroplastic/mitochondrial | / | 0.448 | |
| 2pd8 | FAD | Vivid PAS protein VVD | / | 0.448 | |
| 4du8 | 2P0 | Mevalonate diphosphate decarboxylase | / | 0.448 | |
| 4jrn | ANP | Rhoptry kinase family protein | / | 0.448 | |
| 4die | C5P | Cytidylate kinase | / | 0.447 | |
| 4xj4 | 3AT | Cyclic GMP-AMP synthase | / | 0.447 | |
| 4yqf | GDP | Septin-9 | / | 0.447 | |
| 1g4t | FTP | Thiamine-phosphate synthase | / | 0.446 | |
| 2bpo | NAP | NADPH--cytochrome P450 reductase | / | 0.446 | |
| 2g5c | NAD | Prephenate dehydrogenase | / | 0.446 | |
| 3umv | FAD | Deoxyribodipyrimidine photo-lyase | 4.1.99.3 | 0.446 | |
| 1nuq | NXX | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 | / | 0.445 | |
| 4hj6 | FMN | LOV protein | / | 0.445 | |
| 3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
| 1f20 | NAP | Nitric oxide synthase, brain | 1.14.13.39 | 0.443 | |
| 2ddo | ATP | Pyridoxine/pyridoxal/pyridoxamine kinase | / | 0.443 | |
| 3g2l | LEW | Glycogen phosphorylase, muscle form | 2.4.1.1 | 0.443 | |
| 3lsi | FAD | Pyranose 2-oxidase | / | 0.443 | |
| 4cvl | ACP | UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase | / | 0.442 | |
| 4ien | COA | Putative acyl-CoA hydrolase | / | 0.442 | |
| 1x8v | ESL | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.441 | |
| 1yrc | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 3b4y | F42 | F420-dependent glucose-6-phosphate dehydrogenase | / | 0.441 | |
| 3otf | CMP | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | / | 0.441 | |
| 4bqp | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
| 1k08 | BZD | Glycogen phosphorylase, muscle form | 2.4.1.1 | 0.440 | |
| 1nzd | UPG | DNA beta-glucosyltransferase | / | 0.440 | |
| 1ppj | ANY | Cytochrome b | / | 0.440 | |
| 2a1t | FAD | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 1.3.8.7 | 0.440 | |
| 2be2 | R22 | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
| 2bu2 | ATP | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.440 | |
| 2v1a | FMN | NPH1-1 | / | 0.440 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.440 | |
| 3fp0 | FP0 | 15-O-acetyltransferase | / | 0.440 | |
| 3h06 | VBP | Glutamate receptor 2 | / | 0.440 | |
| 3hl0 | NAD | Maleylacetate reductase | / | 0.440 | |
| 4h8a | NAI | Ureidoglycolate dehydrogenase (NAD(+)) | 1.1.1.350 | 0.440 | |
| 5a3c | NAD | SIR2 family protein | / | 0.440 |